Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Goldman Sachs analyst Brian Lee upgraded Ramaco Resources Inc (NASDAQ:METC) from Sell to Neutral and raised the price target from $14 to $15. Ramaco Resources shares closed at $14.07 on Monday. See how other analysts view this stock.
- Keybanc analyst Eric Heath upgraded Crowdstrike Holdings Inc (NASDAQ:CRWD) from Sector Weight to Overweight and announced a $525 price target. CrowdStrike shares closed at $433.15 on Monday. See how other analysts view this stock.
- Morgan Stanley analyst Michael Ulz upgraded Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) from Equal-Weight to Overweight and raised the price target from $78 to $100. Arrowhead Pharma shares closed at $69.25 on Monday. See how other analysts view this stock.
Considering buying CRWD stock? Here’s what analysts think:
Photo via Shutterstock
Login to comment